406 related articles for article (PubMed ID: 3100473)
1. Immunohistochemical localization for aldose reductase in diabetic lenses.
Akagi Y; Kador PF; Kinoshita JH
Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
[TBL] [Abstract][Full Text] [Related]
2. The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase.
Jedziniak JA; Chylack LT; Cheng HM; Gillis MK; Kalustian AA; Tung WH
Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):314-26. PubMed ID: 6782033
[TBL] [Abstract][Full Text] [Related]
3. Aldose reductase in early streptozotocin-induced diabetic rat lens.
Garadi R; Lou MF
Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2370-5. PubMed ID: 2509397
[TBL] [Abstract][Full Text] [Related]
4. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
5. Regulation of lens aldose reductase activity by nitric oxide.
Srivastava S; Tammali R; Chandra D; Greer DA; Ramana KV; Bhatnagar A; Srivastava SK
Exp Eye Res; 2005 Dec; 81(6):664-72. PubMed ID: 15967436
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase and sorbitol dehydrogenase distribution in substructures of normal and diabetic rat lens.
Collins JG; Corder CN
Invest Ophthalmol Vis Sci; 1977 Mar; 16(3):242-3. PubMed ID: 403152
[TBL] [Abstract][Full Text] [Related]
7. Studies on cataractogenesis in humans and in rats with alloxan-induced diabetes. II. Histochemical evaluation of lenticular enzymes.
Ahmad SS; Tsou KC; Ahmad SI; Rahman MA
Ophthalmic Res; 1985; 17(1):12-20. PubMed ID: 2984623
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
Kubo E; Maekawa K; Tanimoto T; Fujisawa S; Akagi Y
Exp Eye Res; 2001 Sep; 73(3):375-81. PubMed ID: 11520112
[TBL] [Abstract][Full Text] [Related]
9. Regional enzymatic analysis of UV-B and streptozotocin induced diabetic cataract lens.
Kojima M
Lens Eye Toxic Res; 1990; 7(3-4):547-61. PubMed ID: 1966039
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase in diabetic cataracts.
Kinoshita JH; Kador P; Catiles M
JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
[No Abstract] [Full Text] [Related]
11. Implications of aldose reductase in cataracts in human diabetes.
Varma SD; Schocket SS; Richards RD
Invest Ophthalmol Vis Sci; 1979 Mar; 18(3):237-41. PubMed ID: 106020
[TBL] [Abstract][Full Text] [Related]
12. Lens aldose reductase in diabetic and galactosemic cataracts.
Parmar NS; Ghosh MN
Indian J Physiol Pharmacol; 1981; 25(3):193-200. PubMed ID: 6795119
[No Abstract] [Full Text] [Related]
13. Altering the course of cataracts in diabetic rats.
Fukushi S; Merola LO; Kinoshita JH
Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase and its inhibition in the control of diabetic complications.
Narayanan S
Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
[TBL] [Abstract][Full Text] [Related]
15. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
Ao S; Kikuchi C; Ono T; Notsu Y
Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
[TBL] [Abstract][Full Text] [Related]
16. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
[TBL] [Abstract][Full Text] [Related]
17. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
[TBL] [Abstract][Full Text] [Related]
18. [Aldose reductase and its inhibitors. Current data].
Bordat B; Misse P; Bourgeoiset C; Navarre L
Bull Soc Ophtalmol Fr; 1989; 89(6-7):885-9. PubMed ID: 2514048
[No Abstract] [Full Text] [Related]
19. Characterization of aldose reductase activities from human and animal sources by a sensitive fluorescence assay.
Griffin BW; McNatt LG; York BM
Prog Clin Biol Res; 1987; 232():325-40. PubMed ID: 3112786
[No Abstract] [Full Text] [Related]
20. Potential use of aldose reductase inhibitors to prevent diabetic complications.
Zenon GJ; Abobo CV; Carter BL; Ball DW
Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
